JPRN-UMIN000050842招募中Unknown
sofosbuvir/velpatasvir for Japanease patients with hepatitis C - SOF/VEL for hepatitis C in Japan
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Exclusion Criteria 1.Patients who are judged by the research lead to be inappropriate for participation in this review 2.Other persons who are judged by the principal investigator to be inappropriate as research subjects *Patients who discontinue treatment due to adverse drug reactions, etc. will not be excluded from the study.
研究者
相似试验
已完成
不适用
Telaprevir therapy in Japanese patients infected with HCVChronic hepatitis C patientsJPRN-UMIN000007912Chiba University, Graduate School of Medicine200
招募中
Unknown
Efficacy and Safety of sofosbuvir/velpatasvir for HCV infected patients with decompensated LCJPRN-UMIN000050343Hokkaido University Hospital50
已完成
不适用
Selecting treatment duration based on early response to Epclusa in patients with type 3 hepatitis C virus infection – is longer therapy worthwhile?Specialty: Hepatology, Primary sub-specialty: HepatologyUKCRC code/ Disease: Infection/ Sequelae of infectious and parasitic diseases, Infection/ Viral hepatitisInfections and InfestationsHepatitis CISRCTN16857338Queen Mary University of London25
已完成
不适用
Prospective study of Sofosbuvir and Ledipasvir for HCV genotype 1 infected Japanese patientsGenotype 1 infected chronic liver diseasesJPRN-UMIN000019400Osaka City University and affiliated hospitals400
已完成
不适用
Efficacy and safety of sofosbuvir/belpatasvir combination tablets for patients infected with pan-genotypic hepatitis C virusChronic liver disease infected with HCVJPRN-UMIN000035625Saitama Medical University35